Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Paul M. Taslimi"'
Autor:
Wei-Sheng, Huang, Feng, Li, Yongjin, Gong, Yun, Zhang, Willmen, Youngsaye, Yongjin, Xu, Xiaotian, Zhu, Matthew T, Greenfield, Anna, Kohlmann, Paul M, Taslimi, Angela, Toms, Stephan G, Zech, Tianjun, Zhou, Biplab, Das, Hyun G, Jang, Meera, Tugnait, Yihua E, Ye, Francois, Gonzalvez, Theresa E, Baker, Sara, Nadworny, Yaoyu, Ning, Scott D, Wardwell, Sen, Zhang, Alexandra E, Gould, Yongbo, Hu, Weston, Lane, Robert J, Skene, Hua, Zou, Tim, Clackson, Narayana I, Narasimhan, Victor M, Rivera, David C, Dalgarno, William C, Shakespeare
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 80:129084
In the treatment of non-small cell lung cancer (NSCLC), patients harboring exon 20 insertion mutations in the epidermal growth factor receptor (EGFR) gene (EGFR) have few effective therapies because this subset of mutants is generally resistant to mo
Autor:
Biplab Das, Yun Zhang, Theresa E. Baker, Xiaotian Zhu, Emily Y. Ye, Meera Tugnait, Wei-Sheng Huang, Tianjun Zhou, Yongjin Xu, Narayana I. Narasimhan, Yaoyu Ning, Hyun Gyung Jang, William C. Shakespeare, David C. Dalgarno, Paul M. Taslimi, Scott Wardwell, Sen Zhang, Sara Nadworny, Victor M. Rivera, Francois Gonzalvez, Willmen Youngsaye, Anna Kohlmann, Feng Li, Gong Yongjin, Matthew T. Greenfield, Stephan G. Zech
Publikováno v:
Cancer Research. 76:2644-2644
In non-small cell lung cancer (NSCLC), multiple classes of activating mutations have been identified in EGFR and HER2 that vary widely in their sensitivity to available tyrosine kinase inhibitors (TKIs). Erlotinib, gefitinib, and afatinib are approve
Autor:
Gregory R. Bebernitz, Valerie Beaulieu, Bethany A. Dale, Richard Deacon, Alokesh Duttaroy, Jiaping Gao, Melissa S. Grondine, Ramesh C. Gupta, Mesut Kakmak, Michael Kavana, Louise C. Kirman, Jinsheng Liang, Wieslawa M. Maniara, Siralee Munshi, Sunil S. Nadkarni, Herbert F. Schuster, Travis Stams, Irene St. Denny, Paul M. Taslimi, Brian Vash
Publikováno v:
Journal of Medicinal Chemistry; Oct2009, Vol. 52 Issue 19, p6142-6152, 11p
Autor:
Paul M. Taslimi
Publikováno v:
Journal of Chemical Education. 69:61
The description of a simple device that will eliminate the necessity for the use of microcentrifuge tubes for preparation of most DNA samples.
Autor:
Demetre Kolokotronis, Paul M. Taslimi
Publikováno v:
Journal of Chemical Education. 68:58
This method of preparation almost guarantees gradients of excellent quality at the first attempt.
Autor:
Huang WS; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States. Electronic address: weisheng.huang@theseusrx.com., Li F; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Gong Y; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Zhang Y; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Youngsaye W; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Xu Y; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Zhu X; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Greenfield MT; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Kohlmann A; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Taslimi PM; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Toms A; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Zech SG; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Zhou T; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Das B; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Jang HG; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Tugnait M; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Ye YE; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Gonzalvez F; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Baker TE; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Nadworny S; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Ning Y; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Wardwell SD; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Zhang S; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Gould AE; Takeda Development Center Americas, Inc, 95 Hayden Avenue, Lexington, MA 02421, United States., Hu Y; Takeda Development Center Americas, Inc, 95 Hayden Avenue, Lexington, MA 02421, United States., Lane W; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 45 Landsdowne Street, Cambridge, MA 02139, United States., Skene RJ; Takeda Development Center Americas, Inc, 95 Hayden Avenue, Lexington, MA 02421, United States., Zou H; Takeda Development Center Americas, Inc, 95 Hayden Avenue, Lexington, MA 02421, United States., Clackson T; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Narasimhan NI; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Rivera VM; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Dalgarno DC; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States., Shakespeare WC; ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, 26 Landsdowne Street, Cambridge, MA 02139, United States.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2023 Jan 15; Vol. 80, pp. 129084. Date of Electronic Publication: 2022 Nov 21.